The FDA will put three psychedelic drug programs on an ultra-fast approval track, compressing review timelines from roughly 10 to 12 months to as little as one to two months. The agency announced in ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results